Company Encyclopedia
View More
name
Dividend Performers ETF
IPDP.US
News
View More

Will Corporate America’s AI adoption justify the massive capital spending?

Corporate America's AI adoption faces scrutiny over capital spending justification. Investors demand visible AI utilization, but surveys show varied adoption rates. AI capex serves offensive and defensive roles. Companies often lack AI strategies, seeking external help. Accenture and IBM are pivotal in AI consulting, with Accenture expanding partnerships and IBM seeing AI as a software growth driver.

Sherwoodnews·
US
ACN
+0.49%
US
IBM
-0.03%
Sherwoodnews·
US
ACN
+0.49%
US
IBM
-0.03%

Sheets Smith Wealth Management Sells 7,589 Shares of Accenture PLC $ACN

Sheets Smith Wealth Management sold 7,589 shares of Accenture PLC, reducing its position by 39.8% in Q3. Other institutional investors adjusted their holdings, with mixed analyst ratings on Accenture. The stock has an average rating of "Moderate Buy" and a consensus price target of $298.29. Accenture's strategic moves include acquiring Cabel Industry and partnering with the U.S. Department of Energy, impacting its market presence positively.

Market Beat·
US
ACN
+0.49%
Market Beat·
US
ACN
+0.49%

Raub Brock Capital Management LP Acquires 6,779 Shares of Accenture PLC $ACN

Raub Brock Capital Management LP increased its holdings in Accenture PLC by 13.9% in the third quarter, acquiring an additional 6,779 shares. Accenture now represents 2.9% of Raub Brock's portfolio, valued at $13,707,000. Institutional investors own 75.14% of Accenture's stock. Accenture's recent earnings beat estimates, and the company announced a quarterly dividend of $1.63 per share. Positive developments include acquisitions and partnerships, enhancing its market position.

Market Beat·
US
ACN
+0.49%
Market Beat·
US
ACN
+0.49%

Covea Finance Sells 22,300 Shares of Zoetis Inc. $ZTS

Covea Finance reduced its stake in Zoetis Inc. by 7.8% in the third quarter, selling 22,300 shares. Zoetis now represents 1.3% of Covea's holdings. The stock is held by 92.80% institutional investors. Analysts have mixed ratings on Zoetis, with a current average rating of 'Hold' and a price target of $160.18. Zoetis reported strong quarterly earnings and increased its dividend, with a new annual yield of 1.7%.

Market Beat·
US
ZTS
+0.34%
Market Beat·
US
ZTS
+0.34%

U.S. stock market close | Three major indices rise for five consecutive days, S&P and Dow hit new highs before the holiday!

U.S. stock market closed with all three major indices rising, achieving five consecutive days of gains. Both the Dow Jones and S&P 500 set new historical highs, while the Nasdaq remained strong. Macroeconomic data showed moderate employment figures and easing inflation pressures, with investors focusing on the Federal Reserve's next policy moves. Popular stocks such as T2 Biosystems, Yellow Corporation, and Sorrento Therapeutics surged significantly, with funds actively flowing into high-elasticity themes. The top ten trading volumes in the market showed significant divergence, with leading stocks experiencing increased volatility

Market Heartbeat·
US
MRK
+0.15%
US
NKE
+0.55%
Market Heartbeat·
US
MRK
+0.15%
US
NKE
+0.55%
© 2025 Longbridge｜Disclaimer